5 Units of Semaglutide: What the Measurement Tells You

Why are people talking about "5 units" of semaglutide at all?

The phrase comes largely from the world of compounded or grey-market semaglutide, preparations where the medicine is supplied as a powder or liquid that needs to be drawn into a syringe before injection. In those contexts, users sometimes describe their dose in units (a convention borrowed from insulin syringes) or in microlitres, and online forums translate these into shorthand like "5 units" or "10 units". It sounds clinical, but it reflects a system entirely separate from how licensed semaglutide products work in the UK.

Licensed Wegovy pens are pre-filled and pre-set. You click, you inject, you replace the needle. There is no vial, no syringe, no calculation. The dose is fixed by Novo Nordisk and confirmed by your prescriber, not something you measure yourself. If you have come across guidance telling you to draw up 5 units of semaglutide, that guidance relates to a different product category entirely, and one the MHRA has not assessed for safety or efficacy in the UK. For a broader orientation on what licensed semaglutide treatment looks like, the semaglutide overview on this site is a good starting point.

It is also worth knowing that converting between units and milligrams for compounded semaglutide is not straightforward, the answer depends entirely on the concentration of the preparation, which varies between suppliers. That variability is precisely part of what makes unlicensed preparations harder to use safely.

What does the licensed semaglutide schedule actually look like?

For Wegovy in the UK, dosing is described in milligrams and follows a structured titration pathway set by the prescriber, not the patient. Treatment typically begins at 0.25 mg weekly for the first four weeks (a settling-in period designed to reduce the likelihood of nausea and other gastrointestinal side effects) before stepping up toward the 2.4 mg maintenance dose over several months. The Wegovy dosing schedule page covers each stage of this pathway in detail.

The MHRA approved a 7.2 mg higher-maintenance dose for eligible adults in January 2026, and a dedicated single-dose 7.2 mg pen followed in April 2026. Each step on the titration ladder is a clinical decision, not a personal preference: your prescriber looks at how your body is responding, whether side effects are manageable, and whether progression is appropriate. The NHS semaglutide patient page, at nhs.uk/medicines/semaglutide, sets out the full licensed dose range and what to expect at each stage.

None of this can be translated back into "units" in any consistent way, because the pre-filled pen is not a unit-based system. The pen delivers a calibrated volume that contains a precise milligram quantity of semaglutide, the two numbers are only equivalent for one specific licensed product at one specific concentration.

Does "5 units" correspond to any specific point in the Wegovy schedule?

Not in a way that maps reliably onto licensed doses. People sometimes attempt the conversion using the concentration of a particular compounded preparation, for instance, if a vial contains 2 mg of semaglutide per ml and the syringe is marked in 0.01 ml increments, five of those increments might be described as "5 units" and would deliver roughly 0.1 mg. But a different vial concentration gives a completely different milligram result for the same 5 units drawn. There is no universal answer.

For those curious about other volume-to-dose conversions that circulate online, the semaglutide ml to units guide explains the maths and the variables involved. Similarly, if you have seen references to 10 units of semaglutide and wondered how that compares, the same concentration-dependency applies, the milligram content varies depending entirely on which preparation is being used.

The practical upshot: if a number expressed in units is meaningful to you, it is worth asking where that number came from and whether the product behind it is MHRA-licensed. For higher-unit figures like 25 units or beyond, the same question stands.

What arrives when you get semaglutide through a regulated UK pharmacy?

Through a GPhC-registered pharmacy like nume, semaglutide for weight management means a Wegovy pre-filled pen, delivered by DPD the next working day in plain, unbranded packaging, your tracking link arrives by text so you know exactly when to expect it. Inside is the pen itself: a self-contained injector with a dial, no syringe, no vial, no unit markings. Your dose is set. The patient information leaflet inside the box explains storage (refrigerated, 2–8°C) and how to use the pen correctly.

That simplicity is deliberate. One of the advantages of a licensed, pre-filled product is that user error in dosing is largely designed out of the system. There is no calculation to get wrong, no concentration to look up, no conversion from units to milligrams to worry about. The prescriber sets the dose; the pen delivers it. Understanding the cost of private treatment is a fair next step, the Wegovy cost page gives a clear picture of what private semaglutide treatment involves financially. And if you want to explore whether treatment might suit your situation, you can check your eligibility with our prescribers at any point.

Semaglutide is a prescription-only medicine. Whether Wegovy is clinically appropriate depends on your health history, current medications and BMI, factors a prescriber weighs during consultation, as described on the NICE guidance for semaglutide (TA875). That clinical assessment is not a barrier to jump over; it is the part that keeps the medicine working safely for you.